當(dāng)前位置：首頁 JCRQ3 期刊介紹(非官網(wǎng))

Regenerative MedicineSCIE

國際簡稱：REGEN MED 參考譯名：再生醫(yī)學(xué)

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q3

基本信息：: ISSN：1746-0751; E-ISSN：1746-076X; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：ENGLAND; 出版商：Future Medicine Ltd.; 出版語言：English; 出版周期：Bimonthly; 出版年份：2006; 研究方向：醫(yī)學(xué)-工程：生物醫(yī)學(xué)

評價信息：: 影響因子：2.4; H-index：53; CiteScore指數(shù)：4.2; SJR指數(shù)：0.517; SNIP指數(shù)：0.519

發(fā)文數(shù)據(jù)：: Gold OA文章占比：25.41%; 研究類文章占比：70.59%; 年發(fā)文量：51; 自引率：0.0370...; 開源占比：0.2195; 出版撤稿占比：0; 出版國人文章占比：0.1; OA被引用占比：0.3720...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Regenerative Medicine期刊介紹

Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization.

Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community.

Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.

期刊簡介Regenerative Medicine期刊介紹

《Regenerative Medicine》自2006出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點：

預(yù)計審稿時間：較慢,6-12周
醫(yī)學(xué)
CELL & TISSUE ENGINEERING
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Regenerative Medicine Cite Score數(shù)據(jù)

CiteScore：4.2
SJR：0.517
SNIP：0.519

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Embryology	Q2	6 / 21	73%
大類：Medicine 小類：Biomedical Engineering	Q3	162 / 303	46%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻(xiàn)計量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Regenerative Medicine 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	CELL & TISSUE ENGINEERING 細(xì)胞與組織工程 ENGINEERING, BIOMEDICAL 工程：生物醫(yī)學(xué)	4區(qū) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運用科學(xué)計量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級劃分的期刊評價標(biāo)準(zhǔn)。它為我國科研、教育機構(gòu)的管理人員、科研工作者提供了一份評價國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Regenerative Medicine JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CELL & TISSUE ENGINEERING	SCIE	Q4	25 / 31	21%
學(xué)科：ENGINEERING, BIOMEDICAL	SCIE	Q3	73 / 122	40.6%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CELL & TISSUE ENGINEERING	SCIE	Q4	26 / 31	17.74%
學(xué)科：ENGINEERING, BIOMEDICAL	SCIE	Q3	84 / 122	31.56%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
USA87
England59
CHINA MAINLAND35
Slovenia14
Australia13
Canada12
Iran11
Brazil10
Italy10
Japan8

本刊中國學(xué)者近年發(fā)表論文

1、Purified exosome product enhances chondrocyte survival and regeneration by modulating inflammation and promoting chondrogenesis
Author: Shi, Guidong; Long, Zeling; De la Vega, Rodolfo E.; Behfar, Atta; Moran, Steven L.; Evans, Christopher; Zhao, Chunfeng

Journal: REGENERATIVE MEDICINE. 2023; Vol. 18, Issue 1, pp. 55-71. DOI: 10.2217/rme-2022-0132
2、Current knowledge and future perspectives on exosomes in the field of regenerative medicine: a bibliometric analysis
Author: Dai, Yuxuan; Chen, Yu; Hu, Yiming; Zhang, Lianbo

Journal: REGENERATIVE MEDICINE. 2023; Vol. 18, Issue 2, pp. 123-136. DOI: 10.2217/rme-2022-0141
3、EGFL7 affects the migration of epidermal stem cells in refractory diabetic wounds by regulating Notch signaling pathway
Author: Chang, Jinyuan; Sun, Yang; Meng, Xianxi; Zeng, Fanglin; Wang, Xiancheng

Journal: REGENERATIVE MEDICINE. 2023; Vol. 18, Issue 2, pp. 137-153. DOI: 10.2217/rme-2022-0123
4、Strategies of immobilizing BMP-2 with 3D-printed scaffolds to improve osteogenesis
Author: Bi, Zhiguo; Shi, Xiaotong; Liao, Shiyu; Li, Xiao; Sun, Chao; Liu, Jianguo

Journal: REGENERATIVE MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.2217/rme-2022-0222
5、Identification of the MALAT1/miR-106a-5p/ZNF148 feedback loop in regulating HaCaT cell proliferation, migration and apoptosis
Author: Kuang, Li-Wen; Zhang, Chen-Chen; Li, Bing-Hui; Liu, Hui-Zhen; Wang, Hui; Li, Gong-Chi

Journal: REGENERATIVE MEDICINE. 2023; Vol. 18, Issue 3, pp. 239-258. DOI: 10.2217/rme-2022-0189
6、Exosomes derived from human dental pulp stem cells increase flap survival with ischemia-reperfusion injuries
Author: Shi, Xin; Yang, Guang; Liu, Ming-yue; Yuan, Meng-tong; Wang, Dong; Wang, Xiao-feng

Journal: REGENERATIVE MEDICINE. 2023; Vol. 18, Issue 4, pp. 313-327. DOI: 10.2217/rme-2022-0206
7、Mapping theme trends and knowledge structure on adipose-derived stem cells: a bibliometric analysis from 2003 to 2017.
Author: Shi B^1,², Wei W^3,⁴, Qin X^1,⁵, Zhao F⁶, Duan Y¹, Sun W¹, Li D⁷, Cao Y¹.

Journal: Regen Med. 2019 Jan;14(1):33-48. doi: 10.2217/rme-2018-0117. Epub 2018 Dec 14.
8、Intravascular cell therapy in stroke: predicting the future trends.
Author: Cui L^1,², Moisan A^3,⁴, Jolkkonen J^2,⁵.

Journal: Regen Med. 2019 Jan;14(1):63-68. doi: 10.2217/rme-2018-0037. Epub 2018 Dec 18.